Melatonin: a potential therapeutic option for breast cancer

X Kong, R Gao, Z Wang, X Wang, Y Fang, J Gao… - Trends in Endocrinology …, 2020 - cell.com
Melatonin has significant inhibitory effects in numerous cancers, especially breast cancer. In
estrogen receptor (ER)-positive human breast cancer, the oncostatic actions of melatonin …

Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment

Y Li, X Kong, L Xuan, Z Wang… - Journal of cellular and …, 2021 - Wiley Online Library
Breast cancer, a hormone‐dependent tumour, generally includes four molecular subtypes (luminal
A, luminal B, HER2 enriched and triple‐negative) based on oestrogen receptor, …

[HTML][HTML] PD-1/PD-L1 inhibitor-associated myocarditis: epidemiology, characteristics, diagnosis, treatment, and potential mechanism

…, Y Qi, X Kong, Z Wang, Y Fang, J Wang - Frontiers in …, 2022 - frontiersin.org
Immune checkpoint inhibitors (ICIs) induce T-cell activation against cancer cells, and due to
their anti-tumor function in multiple cancers, ICIs have been considered an important option …

[HTML][HTML] Prognostic nutritional index (PNI) in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator

…, S Huang, Z Wang, X Wang, Y Fang, J Wang - Frontiers in cell and …, 2021 - frontiersin.org
Objective Prognostic nutritional index (PNI), calculated as serum albumin (ALB) (g/L) + 5 ×
total lymphocyte count (10 9 /L), is initially used to evaluate nutritional status in patients …

Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy

…, Z Wang, X Wang, Y Fang, J Wang - Journal of cellular …, 2020 - Wiley Online Library
The systemic immune‐inflammation index (SII = N × P/L) based on neutrophil (N), platelet (P)
and lymphocyte (L) counts is used to predict the survival of patients with malignant tumours …

[HTML][HTML] Comprehensive analysis of the expressionand prognosis for TDO2 in breast cancer

…, X Kong, X Wang, Z Wang, Y Fang, J Wang - Molecular Therapy …, 2020 - cell.com
A plethora of previous studies have been focused on the role of indoleamine 2,3-dioxygenase
1 (IDO1) in cancer immunity; however, the alternative way of targeting tryptophan 2,3-…

[HTML][HTML] LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1

…, X Yang, J Zhai, R Gao, Y Qi, J Wang, Z Wang… - Cell death & …, 2019 - nature.com
Previously, several protein-coding tumor suppressors localized at 1p36 have been reported.
In the present work, we focus on functional long non-coding RNAs (lncRNAs) embedded in …

Pretreatment systemic inflammation response index in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator

…, Z Wang, X Wang, Y Fang, J Wang - Cancer Management …, 2020 - Taylor & Francis
Background and Objective Systemic inflammation response index (SIRI=N×M/L), based on
neutrophil (N), monocyte (M), and lymphocyte (L) counts, is used to predict the survival of …

[HTML][HTML] Subsequent risk of suicide among 9,300,812 cancer survivors in US: A population-based cohort study covering 40 years of data

Q Liu, X Wang, X Kong, Z Wang, M Zhu, Y Ren… - …, 2022 - thelancet.com
Background Large cohort studies that estimate the variation in suicide risk among cancer
patients, depending on disease type and patient characteristics, are lacking. We aimed to …

[HTML][HTML] Butyrate emerges as a crucial effector of Zhi-Zi-Chi decoctions to ameliorate depression via multiple pathways of brain-gut axis

J Liu, Y Fang, L Cui, Z Wang, Y Luo, C Gao… - Biomedicine & …, 2022 - Elsevier
Gut microbiota has emerged as a crucial target of gut-brain axis to influence depression. Zhi-Zi-Chi
decoctions (ZZCD), as a classic oral formula in clinic, is widely applied in depression …